Litigation Details for Cesar Castillo, Inc. v. Takeda Pharmaceutical Company Limited (S.D.N.Y. 2015)
✉ Email this page to a colleague
Cesar Castillo, Inc. v. Takeda Pharmaceutical Company Limited (S.D.N.Y. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-05-04 |
| Court | District Court, S.D. New York | Date Terminated | |
| Cause | 15:2 Antitrust Litigation | Assigned To | Ronnie Abrams |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,150,384; 6,166,042; 6,166,043; 6,172,090; 6,211,205; 6,271,243; 6,303,640; 6,329,404 | ||
| Link to Docket | External link to docket | ||
Details for Cesar Castillo, Inc. v. Takeda Pharmaceutical Company Limited (S.D.N.Y. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-05-04 | 1 | other patents to the FDA for listing in the Orange Book:: ) June 19, 2 6,150,384 (the “…Combo Patent and the ‘404 Insulin Patent as drug product patents claiming Actos only if the patents in fact…submitted patent information to the FDA describing the ‘584 Combo Patent as a drug product patent that claims…submitted patent information to the FDA describing the ‘404 Insulin Patent as a drug product patent that claims…to the ‘777 Compound Patent, the ‘584 Combo Patent, and the ‘404 Insulin Patent, Takeda submitted eight | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
